PFM
GILD icon

Parsec Financial Management’s Gilead Sciences GILD Stock Holding History

Parsec Financial Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-39,723
Closed -$2.88M – 304
2021
Q4 		$2.88M Sell
39,723
-4,333
-10% -$298K 0.12% 114
2021
Q3 		$2.91M Sell
44,056
-6,254
-12% -$439K 0.12% 110
2021
Q2 		$3.46M Sell
50,310
-13,867
-22% -$926K 0.16% 95
2021
Q1 		$4.15M Sell
64,177
-42,745
-40% -$2.76M 0.21% 82
2020
Q4 		$6.23M Sell
106,922
-42,462
-28% -$2.56M 0.34% 61
2020
Q3 		$9.44M Sell
149,384
-26,500
-15% -$1.84M 0.58% 46
2020
Q2 		$13.5M Sell
175,884
-15,270
-8% -$1.17M 0.86% 37
2020
Q1 		$14.3M Sell
191,154
-21,220
-10% -$1.47M 1.07% 30
2019
Q4 		$13.8M Sell
212,374
-15,862
-7% -$1.03M 0.81% 46
2019
Q3 		$14.5M Sell
228,236
-5,507
-2% -$360K 0.91% 45
2019
Q2 		$15.8M Buy
233,743
+111,857
+92% +$7.36M 0.98% 40
2019
Q1 		$7.92M Buy
121,886
+15,783
+15% +$1.05M 0.5% 62
2018
Q4 		$6.64M Buy
106,103
+10,000
+10% +$699K 0.48% 61
2018
Q3 		$7.42M Buy
96,103
+2,485
+3% +$188K 0.47% 64
2018
Q2 		$6.63M Buy
93,618
+1,412
+2% +$99.7K 0.45% 65
2018
Q1 		$6.95M Buy
92,206
+700
+0.8% +$55.6K 0.47% 64
2017
Q4 		$6.55M Sell
91,506
-3,178
-3% -$241K 0.44% 67
2017
Q3 		$7.67M Buy
94,684
+11,771
+14% +$900K 0.56% 60
2017
Q2 		$5.87M Buy
82,913
+3,708
+5% +$247K 0.47% 72
2017
Q1 		$5.38M Buy
79,205
+30,614
+63% +$2.15M 0.45% 71
2016
Q4 		$3.48M Buy
48,591
+4,840
+11% +$360K 0.3% 87
2016
Q3 		$3.46M Buy
43,751
+8,434
+24% +$685K 0.31% 84
2016
Q2 		$2.95M Buy
35,317
+3,706
+12% +$329K 0.28% 89
2016
Q1 		$2.9M Buy
31,611
+20,706
+190% +$1.87M 0.29% 88
2015
Q4 		$1.1M Buy
10,905
+5,972
+121% +$621K 0.11% 114
2015
Q3 		$484K Buy
4,933
+1,534
+45% +$170K 0.05% 131
2015
Q2 		$398K Buy
+3,399
New +$371K 0.04% 143

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parsec Financial Management's GILD Position: Q1 2022 in Review

Parsec Financial Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 39,723 shares — an estimated $2.88M sold.

Parsec Financial Management first reported a position in GILD in Q2 2015 and held it in 27 quarters. The position peaked at $15.8M in Q2 2019. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Parsec Financial Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Parsec Financial Management sold 39,723 Gilead Sciences shares in Q1 2022, an estimated $2.88M.
  • Parsec Financial Management first reported a position in Gilead Sciences in Q2 2015 and held it in 27 quarters.
  • Parsec Financial Management's Gilead Sciences position peaked at $15.8M in Q2 2019.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Parsec Financial Management's 13F filing for Q1 2022, filed 9 May 2022.